NeuroScientific specialist hire sets stage for major Crohn’s trial

The Sydney Morning Herald - Oct 1, 2026

NeuroScientific Biopharmaceuticals has hired Southern Star Research for a phase two trial of its StemSmart Crohn’s disease therapy in Australia and the US.

Read full article

More News

Sign Up Now

Subscribe to us for the latest news from Banking Reporter

Banking Reporter

Banking Reporter is the largest-circulated online business news in the United States, bringing a whole new genre of business journalism more up close and more incisive.